Minnesota · 2025-2026 Regular Session · Bill

HF 4349: Provisions governing hospital reimbursement for biological products to treat rare diseases modified.

In committee Last action March 16, 2026: Introduction and first reading, referred to Health Finance and Policy

Plain-language summary

HF 4349 is a bill introduced in the Minnesota House on March 16, 2026. According to its official title, it concerns: Provisions governing hospital reimbursement for biological products to treat rare diseases modified. Primary sponsor: Robert Bierman (Democratic-Farmer-Labor). It lists 4 additional sponsors. Most recent recorded action (March 16, 2026): Introduction and first reading, referred to Health Finance and Policy.

Sponsors

Primary sponsor: Robert Bierman (Democratic-Farmer-Labor). 4 co-sponsors.